期刊文献+

高通量血液透析和血液透析滤过的临床观察 被引量:1

Clinical Observation of High-flux Hemodialysis and Hemodiafiltration
下载PDF
导出
摘要 目的研究高通量血液透析(HPD)和血液透析滤过(HDF)对维持性血液透析患者溶质清除效果及治疗平稳性。方法将26例维持性血液透析患者随机分为2组:HPD组和HDF组,HPD组用金宝AK-95行HPD,HDF组用AK-200US on-line行HDF,两组均采用碳酸氢盐透析液,透析液流量500ml/min,F-60血滤器,时间均为4h/次,3~5次/2周,血流量250~300ml/min;每组随机抽取10份透析前后Bun、Cr、β2-MG、P及3个月后β2-MG,计算溶质清除率;同时观察每组治疗期间及间期症状及体征。结果两组在清除小分子方面疗效相似,在清除中分子上两者明显优于普通血液透析。结论HPD和HDF对中分子及小分子物质的清除率高,治疗过程平稳,是理想的净化方式。 Objective To study the effect of cleaning solute and therapeutic stability about high-flux hemodialysis and hemodiafiltration for patients through maintenance hemodialysis. Methods The 26 patients through maintenance hemodialysis were divided into two groups at random, HPD group and HDF group. The first one was therapied by HPD with AK-95, the other one by HDF with AK-200US on-line, and all the two groups were therapied by dialysis with bicarbonate dialyzate. The flow rate of dialyzate was 500 ml/min,F-60 blood filt,all the time was 4 h once, 3 - 5 orders/2weeks, and BF 250 - 300 ml/min. Every group was taken to 10 portions of BUN, Cr,132-MG, P pro-dialy sis and post-dialysis and β2-MG 3 months later, and calculated the clearance rate of soulte. At the same time the symptom and sings of the two groups in the stage and intermediate stage of therapy. Results The two groups had similar curative effect in the aspect of cleaning micromolecules, and they were outstriped the ordinary, hemodialysis in the aspect of cleaning molecule obviously. Conclusion HPD and HDF is an ideal hematodialysis way, with hypsi-clearance for micronlolecules and molecule, and therapic course is steady.
出处 《透析与人工器官》 2007年第2期17-18,共2页 Chinese Journal of Dialysis and Artificial Organs
关键词 高通量血液透析 血液透析滤过 high-flux hemodialysis hemodiafiltration
  • 相关文献

参考文献2

二级参考文献28

  • 1龚德华,季大玺,谢红浪.高通量透析器复用的研究[J].医学研究生学报,2000,13(5):307-310. 被引量:26
  • 2Jacobs C, Kjellstrand CM, Koch KM, Winchester JF ( Editor-inchief). Keplacement of renal function by dialysis. 4th Revised Edition, Mrtherland: Lluwer Academic publisher, 1996:432
  • 3Ley poldt JK, Cheung AK, Clark WR, et al. Characterization of low and high-flux dialyzers NIH HEMO study: Interim report(Abstract).J Am Soc Nephrol, 1996,7:1518.
  • 4K linkmann H. , Vienken J . Membranes of dialysis. Nephrol Dia Transplant, 1995, (10) S3:39.
  • 5Leto E, Bilal F, Osmic I. Efficiency of high-flux dialysis in removal of beta-microglobulin. Med Ash, 2001,55(4) :225.
  • 6Schiffl H, Fischer R, Lang SM, et al. Clinical manifestations of ABanyloidosis:effeets of biocompatibility and flux. Nephrol Dia Transplant, 2000,15:840.
  • 7Kucharska E, Stompor T, Salowicz W,et al. Kenal osteodystrophy in dialysis patients as estimated by three-point bone densitometry. Prezgl Lek. 2000,57(6) :334.
  • 8Lugon JR, Andre ME, Duarte ME,et al. Effects of in center daily hemodialysis upon mineral metabolism and bone disease in and-stage renal disease patients. Sao Paulo Med J, 2001,119(3) :105.
  • 9Dumler F, Stalla K, Mohini R,et al. Clinical experience with short time hemodialysis. Am J Kidney Dis, 1992,19:49.
  • 10Blankestijn PJ. Hemodialysis using high flux membranes improve lipid profile. Clin Nephrol, 1994,42: S48.

共引文献77

同被引文献14

引证文献1

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部